Patents Represented by Attorney, Agent or Law Firm Bernard Lau
-
Patent number: 6664284Abstract: Ready-to-use, aqueous injection solutions containing carvedilol (1-(9H-carbazolyl-4-yloxy)-3-[[(2-(2-methoxyphenoxy)ethyl]-amino]-2-propanol) or its pharmacologically harmless salts which are stable in storage and are well tolerated by veins are disclosed.Type: GrantFiled: May 1, 2002Date of Patent: December 16, 2003Assignee: Roche Diagnostics GmbHInventors: Werner Gruber, Heinrich Woog
-
Patent number: 6660736Abstract: This invention relates to phthalimido derivatives of the formula wherein X is —N═ or —CH═, and R1 to R4 and m are as defined in the specification, as well as their pharmaceutically acceptable salts. The invention further relates to pharmaceutical compositions containing these compounds, a method of treating a disease by administering a therapeutically effective amount of at least one of these compounds, and a process for their preparation for the treatment or prevention of diseases in which MAO-B inhibitors might be beneficial.Type: GrantFiled: March 13, 2003Date of Patent: December 9, 2003Assignee: Hoffmann-La Roche Inc.Inventors: Andrea Cesura, Rosa Maria Rodriguez Sarmiento, Andrew William Thomas, Rene Wyler
-
Patent number: 6627221Abstract: The invention relates to a solid pharmaceutical form of administration containing a diphosphonic acid or a physiologically compatible salt thereof as the active substance, wherein the active substance is present in granulate form, optionally together with pharmaceutical adjuvants in the inner phase, and the outer phase contains a lubricant in the form of less than 5% by weight of stearic acid relative to the total weight of the form of administration.Type: GrantFiled: July 20, 2001Date of Patent: September 30, 2003Assignee: Hoffmann-La Roche Inc.Inventors: Rolf-Dieter Gabel, Walter Preis, Heinrich Woog
-
Patent number: 6617346Abstract: The present invention provides compounds according to formula I and formula II and pharmaceutically acceptable salts and esters thereof, having the designations provided herein and which inhibit the interaction of MDM2 protein with a p53-like peptide and have antiproliferative activityType: GrantFiled: December 11, 2002Date of Patent: September 9, 2003Assignee: Hoffmann-La Roche Inc.Inventors: Norman Kong, Emily Aijun Liu, Binh Thanh Vu
-
Patent number: 6603012Abstract: New compounds containing bicyclic fused rings, one of which being a phenyl moiety connected by an aliphatic chain to a cycloalkyl or aryl moiety, and pharmaceutically active salts thereof are useful as RAR selective retinoid agonists. Furthermore, such retinoic acid receptor agonists, particularly retinoic acid receptor &ggr; (RAR&ggr;) selective agonists, are useful for the treatment of emphysema and associated pulmonary diseases, as well as for the therapy and prophylaxis of dermatological disorders, for the therapy and prophylaxis of malignant and premalignant epithelial lesions, tumors and precancerous changes of the mucous membrane in the mouth, tongue, larynx, esophagus, bladder, cervix and colon.Type: GrantFiled: April 23, 2001Date of Patent: August 5, 2003Assignee: Hoffmann-La Roche Inc.Inventors: Paula Nanette Belloni, Synese Jolidon, Michael Klaus, Jean-Marc Lapierre
-
Patent number: 6562977Abstract: The present invention is concerned with mixed anhydrides. The mixed anhydrides are prepared by adding an adjuvant base to a mixture of acid and reactive acid derivative. The mixed anhydrides play an role primarily in activating and coupling reactions.Type: GrantFiled: December 6, 2001Date of Patent: May 13, 2003Assignee: Hoffmann-La Roche Inc.Inventors: Martin Karpf, René Trussardi
-
Patent number: 6541638Abstract: The present invention relates to pyrrolidine derivatives and dimeric forms and/or pharmaceutically acceptable esters, and/or salts thereof. The compounds are useful as inhibitors of metalloproteases, e.g. zinc proteases, particularly zinc hydrolases, and which are effective in treating disease states are associated with vasoconstriction of increasing occurrences.Type: GrantFiled: July 17, 2001Date of Patent: April 1, 2003Assignee: Hoffman-La Roche Inc.Inventors: Johannes Aebi, Denise Blum, Daniel Bur, Alexander Chucholowski, Henrietta Dehmlow, Eric Argirios Kitas, Bernd Michael Loeffler, Ulrike Obst, Sabine Wallbaum
-
Patent number: 6537794Abstract: The present invention relates to the discovery of novel genes and proteins, which function in pathways involved in brain pathogenesis. In particular, the novel genes and proteins relate to inflammatory tissue responses caused by brain injuries such trauma, ischemia or autoimmune-inflammation or other diseases or processes related to neuroinflammation. The compounds disclosed in the present invention are useful as therapeutics, diagnostics and in screening assays.Type: GrantFiled: October 25, 1999Date of Patent: March 25, 2003Assignee: Hoffmann-La Roche Inc.Inventors: Werner Lesslauer, Ulrike Utans-Schneitz
-
Patent number: 6512123Abstract: Compounds of formula I wherein R1, R2, A, X, Y and Z have the meanings provided in the specification, and their enantiomers, diastereoisomers, racemates, pharmaceutically acceptable salts and mixtures thereof. These compounds have HDAC inhibitory activity for inhibiting cell proliferation. Also provided is a process of manufacturing these compounds.Type: GrantFiled: April 22, 2002Date of Patent: January 28, 2003Assignee: Hoffmann-La Roche Inc.Inventors: Adelbert Grossmann, Wolfgang von der Saal, Tim Sattelkau, Ulrich Tibes
-
Patent number: 6469163Abstract: An improvement in the conventional process for the production of caprolactam. The process involves: (a) reacting air with ammonia gas in an ammonia conversion zone to produce nitric oxide; (b) oxidizing a portion of the nitric oxide to nitrogen dioxide to produce an NOx-rich process gas stream; (c) reacting the NOx-rich stream with ammonium carbonate in a nitriting zone to produce ammonium nitrite; (d) reducing the ammonium nitrite to hydroxylamine diammonium sulfate; (e) hydrolyzing the hydroxylamine diammonium sulfate to hydroxylamine sulfate; (f) oximating the hydroxylamine sulfate with cyclohexanone to produce cyclohexanone oxime; and (g) converting the cyclohexanone oxime to caprolactam. The process is improved by adding supplemental oxygen downstream of the ammonia conversion zone to increase the quantity and rate of formation of nitrogen dioxide in the NOx-rich process gas stream.Type: GrantFiled: December 24, 1998Date of Patent: October 22, 2002Assignee: Praxair Technology Inc.Inventors: Diego Fernandez Echegaray, Antonio Augusto M. Velloso, Matthew Lincoln Wagner
-
Patent number: 6442536Abstract: This invention is directed to a method for predicting the flammability of complex mixtures using critical variables of structural groups comprising training data from the critical variables of each structural groups, the critical variables comprising compositional and thermochemical data from each of the structural groups to produce a neural network model; testing the trained data from the neural network model; and validating the trained and tested data from the neural network to accurately predict the flammability limit of an analogous complex mixture having similar structural groups.Type: GrantFiled: January 18, 2000Date of Patent: August 27, 2002Assignee: Praxair Technology, Inc.Inventors: Amer Wahid Akhras, Matthew Lincoln Wagner
-
Patent number: 6425265Abstract: A process for removing impurities such as oxygen, nitrogen, carbon monoxide, hydrogen, water (moisture), carbon dioxide, hydrogen chloride, methane and trace metals from crude hydrogen bromide and the apparatus for purifying such crude hydrogen bromide.Type: GrantFiled: September 26, 2001Date of Patent: July 30, 2002Assignee: Praxair Technology, Inc.Inventors: Arthur Edward Holmer, James Philip Natwora, Jr., Sateria Salim
-
Patent number: 6420583Abstract: This invention is directed to a method for synthesizing a carbonyl based compound under neat conditions comprising refluxing a metal carbonyl compound with an excess of neutral ligand to produce a first mixture; evaporating any excess neutral ligand from the first mixture to produce a second mixture; and distilling the second mixture to produce the carbonyl based compound.Type: GrantFiled: September 27, 2001Date of Patent: July 16, 2002Assignee: Praxair Technology, INCInventors: Michael Alexander Lienhard, Cynthia A. Hoover
-
Patent number: 6410885Abstract: This invention is directed to a MIG brazing power source having a transformer and an inductor. Each of the transformer and inductor has a magnetic core and a coil having specific characteristics.Type: GrantFiled: May 3, 2001Date of Patent: June 25, 2002Assignee: Praxair Technology, Inc.Inventors: João Vinicius De Oliveira Correia, William De Abreu Macedo, Giancarlo Riccardo Cavalli
-
Patent number: 6398546Abstract: This invention is directed to a method for carrying out combustion in a furnace having porous walls with a large surface area comprising providing a combustion zone containing an atmosphere of furnace gases. A low velocity oxidant stream is injected through at least one oxidant injection side of the porous walls into the combustion zone and mixing furnace gases with the oxidant stream in a mixing zone within the combustion zone to produce an oxidant mixture. A fuel stream is injected through at least one fuel injection side adjacent to the oxidant injection side in the combustion zone. The oxidant mixture is mixed with the fuel stream to create a fuel-oxidant mixture.Type: GrantFiled: June 21, 2000Date of Patent: June 4, 2002Assignee: Praxair Technology, Inc.Inventor: Hisashi Kobayashi
-
Patent number: 6346138Abstract: This invention is directed to a method and system for purifying hexafluoroethane near its critical temperature and pressure, particularly where the hexafluoroethane contains at least about 1 ppb by weight of a non-volatile residue. A combination of a sand trap, an adsorption assembly made of a glass wool-molecular sieve-glass wool combination, and a filter is used.Type: GrantFiled: September 1, 1999Date of Patent: February 12, 2002Assignee: Praxair Technology, Inc.Inventor: Arthur Edward Holmer
-
Patent number: 6333411Abstract: A method for production of caprolactam. The method involves: (a) reacting air with ammonia gas in an ammonia conversion zone to produce nitric oxide; (b) oxidizing at least a portion of the nitric oxide to nitrogen dioxide to produce an NOx-rich process gas stream; (c) reactively absorbing the NOx-rich gas stream with phosphoric acid containing solution in an absorption zone to form nitrate ions; (d) contacting the nitrate ions with air in a degassing zone to produce a nitrate-rich aqueous process stream; (e) reducing the nitrate-rich aqueous stream with hydrogen in the presence of phosphoric acid to produce hydroxylammonium phosphate; (f) oximating the hydroxylammonium phosphate with cyclohexanone to produce cyclohexanone oxime; and (g) converting the cyclohexanone oxime to caprolactam. According to the invention, supplemental oxygen is added downstream of the ammonia conversion zone to increase the quantity and rate of formation of nitrogen dioxide in the NOx-rich process gas stream.Type: GrantFiled: December 24, 1998Date of Patent: December 25, 2001Assignee: Praxair Technology, Inc.Inventors: Diego Fernandez Echegaray, Antonio Augusto M. Velloso, Matthew Lincoln Wagner
-
Patent number: 6324852Abstract: An apparatus for and method of delivering a liquid cryogen into a reaction vessel to cool an exothermic reaction within the vessel wherein the liquid cryogen can be supplied directly into the reaction vessel at a maximum high pressure of about 3000 psi is provided. The liquid cryogen may come directly from a high pressure liquid cryogen storage tank without any pressure regulators or control valves between the reaction vessel and the storage tank thereby reducing flashing and eliminating the need for sub-cooling the liquid cryogen.Type: GrantFiled: January 24, 2000Date of Patent: December 4, 2001Assignee: Praxair Technology, Inc.Inventor: Alan Tat Cheng
-
Patent number: 6280996Abstract: A method for carrying out fermentation comprising the steps of providing a vessel with elevated pressure up to 25 atm which contains a broth comprising a constituent capable of undergoing fermentation, lowering the vessel pressure within the vessel to lower the equilibrium oxygen partial pressure, adding pure oxygen into the vessel to raise the equilibrium oxygen partial pressure therein, and utilizing the pure oxygen to carry out the fermentation of the constituent.Type: GrantFiled: March 22, 1999Date of Patent: August 28, 2001Assignee: Praxair Technology, Inc.Inventor: Alan Tat Yan Cheng
-
Patent number: 6273402Abstract: An apparatus and method for mixing a gas and a liquid while concomitantly mixing and suspending solids and sludge at the bottom of a deep tank. The present invention includes a gas-liquid aerator which is adapted to be submerged below the surface of wastewater in a deep tank. An expanding high velocity gas-liquid mixture is caused to exit from the bottom of the submerged aerator device with enough force to mix and suspend settling solids and sludge at the bottom of the deep tank.Type: GrantFiled: January 10, 2000Date of Patent: August 14, 2001Assignee: Praxair Technology, Inc.Inventor: Alan Tat Yan Cheng